Breaking News on Global Pharmaceutical Technology & Manufacturing

Capsugel invests in vegetarian capsules citing demand for lower moisture content and API cross-linking risk

26-Mar-2015 - Capsugel will invest $25m (€22m) to expand production of vegetarian-friendly drug and food supplement capsules.

Biohaven opts for Zydis delivery tech for anxiety pill

26-Mar-2015 - Biohaven Pharmaceutical has created a melt in the mouth anxiety drug using formulation technology licensed from Catalent.

Pharma moves into 3D printing with customizable drug delivery devices

19-Mar-2015 - 3D printers have been used to create tailor-made drug delivery tools, including bioactive radiology devices.

Small revolution: nanotech to be the next big thing in cancer drug delivery, report

18-Mar-2015 - More cancer drugs are going to be delivered using nanoparticles according to Frost & Sullivan, which says research breakthroughs are going to drive adoption of such technologies.

WHO: Smart needles key to preventing new hep B infections

12-Mar-2015 - New hepatitis B treatment guidelines advocate use of Gilead and BMS drugs and underline WHO concerns that needle reuse spreads the virus.

Every small molecule helps: Type 1 diabetes vaccine set for trials this year says researcher

11-Mar-2015 - A type 1 diabetes vaccine will enter human trials this year according to the leader of the UK research team developing a preventative therapy for the autoimmune disorder.

Why PKC inhibitors fail: Protein Kinase Cs suppress tumours according to new study

10-Mar-2015 - Cancer Drug firms trying to block protein kinase Cs should rethink say researchers behind a study indicating that the enzymes suppress tumour development.

Anthrax vaccine stability data delivers contract extension for Glide Technologies

09-Mar-2015 - US desire for an alternative to the current multi-shot anthrax vaccine is a boon for delivery systems firm Glide Technologies, which had its contract extended by Pfenex this week.

3D pill printing firm Aprecia leases Forest Labs site as production hub

02-Mar-2015 - 3D drug printing firm Aprecia Pharmaceutical has leased an old Forest Labs facility sold following the firm’s $28bn takeover by Actavis last year .

Sosei, so good: Heptares' collaborations to continue post takeover

26-Feb-2015 - Sosei's takeover will not impact Heptares's antibody tech collaboration with Morphosys according to the UK membrane protein specialist.

Salix latest purchase by Valeant after Dendreon deal

26-Feb-2015 - Valeant has signed a $14.5bn deal to acquire GI drugmaker Salix days after agreeing to purchase Provenge-maker Dendreon.

Syringe reuse not clever: WHO advocates use of "smart" syringes to stop disease spread

23-Feb-2015 - ‘Smart’ syringes that can’t be reused should be the drug and vaccine delivery technology of choice for healthcare programmes according to the WHO, which says needle reuse is spreading deadly infectious diseases.

Drug delivery tech’s shares skyrocket as it helps Novo Nordisk clear Phase II hurdle

23-Feb-2015 - A potential Type 2 diabetes drug from Novo Nordisk has met the primary endpoint of a Phase II trial and shares of Emisphere Technology, which helped to formulate the oral version of semaglutide, jumped by as much as 70% on Friday.

Lupin plans to take on GSK’s Advair and Forest Labs’s Aerochamber in the US

18-Feb-2015 - Lupin will co-develop a rival to GSK’s Advair in the US and has licensed rights to an inhaled drug delivery tech competitor for Forest Labs’s Aerochamber.

Targeting stem cell cilia could prevent obesity and yield new cancer and arthritis drugs say researchers

17-Feb-2015 - Having shorter hair stops you becoming fat…at least it does if you are a stem cell say researchers who claim restricting the growth of hair-like cilia found on such cells could yield new treatments for obesity.

Suboxone sales down as opioid addiction drug market intensifies

12-Feb-2015 - Opioid addiction drug Suboxone lost market share in 2014 according to newly independent Indivior, whose management says it is not intimidated by increased competition.

Ex-Unigene execs who run Enteris add API contracting service to delivery tech licensing business

12-Feb-2015 - Enteris BioPharma has broadened its business beyond drug delivery tech licensing and launched a contract API manufacturing service.

One in the eye for Lucentis? Pfenex says Pfizer takeover will benefit Hospira pact

11-Feb-2015 - Pfenex expects its new Lucentis biosimilar partnership to benefit from Pfizer’s economic clout after the Hospira takeover completes.

Unilife upping device production as market opportunity offsets flat sales

10-Feb-2015 - Unilife Corporation has ramped up production of delivery devices as pharmas looks to differentiate injectable therapies from the competition.

update: WHO says tech like Nanopatch can help get vaccines to the people that need them

Vaxxas raises $20m for nanopatch vaccine trials

10-Feb-2015 - Vaccine patch firm Vaxxas has raised $20m (€17.7m) to fund clinical development of its pipeline of influenza, polio and bacterial infection vaccines.

GSK to consolidate vaccines R&D ahead of Novartis unit takeover

09-Feb-2015 - GSK will close a vaccine R&D lab in Montana and establish a centralised development hub as it prepares to takeover Novartis jabs unit.

Chinese researchers develop nanocarrier for pancreatic cancer drug

09-Feb-2015 - Researchers from the Oncology Department of Tianjin Medical University Cancer Hospital in China recently published a study in Advanced Functional Materials  announcing the creation of a new nano-carrier for pancreatic cancer treatments.

Water Street targets generic injectables sector with CMO buy

05-Feb-2015 - Water Street Healthcare Partners has bought US generic injectables contractor Custopharm.

Inhaled insulin: Sanofi alone as Big Pharma declines to revisit past

04-Feb-2015 - Pfizer, Lilly and Novo Nordisk will not be revisiting inhaled insulin opportunities despite the US launch and expected success of Sanofi and MannKind’s Afrezza.

Google picks Biogen Idec MS project for research partnership

29-Jan-2015 - Google and Biogen Idec are teaming up to crack multiple sclerosis, the latest crossover between pharma and the wearables world.


Message is clear: Europe is in trouble in terms of pharma growth, experts say
Dispatches from DCAT

Message is clear: Europe is in trouble in terms of pharma growth, experts say

The European pharma market isn’t likely to deliver much growth over the next five years as generic...

Distributing donated drugs a major challenge says UK neglected diseases group

Distributing donated drugs a major challenge says UK neglected diseases group

More drugs for tropical diseases have been donated since the London declaration of 2012, but getting them...

'Black Mamba' or 'OMG': which fake sex pill has the best name?

'Black Mamba' or 'OMG': which (fake) sexual enhancement pill has the best name?

The FDA has tested hundreds of creatively named bogus supplements and found they contain hidden APIs. Take...